Total Payments
$14,720
2024 Payments
$2,928
Companies
53
Transactions
922
Medicare Patients
3,599
Medicare Billing
$582,556
Payment Breakdown by Category
Food & Beverage$14,538 (98.8%)
Education$162.49 (1.1%)
Consulting$20.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,538 | 918 | 98.8% |
| Education | $162.49 | 3 | 1.1% |
| Consulting Fee | $20.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,581 | 135 | $0 (2024) |
| Amgen Inc. | $2,098 | 168 | $0 (2024) |
| UCB, Inc. | $1,703 | 109 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,239 | 70 | $0 (2024) |
| GlaxoSmithKline, LLC. | $862.86 | 59 | $0 (2024) |
| Janssen Biotech, Inc. | $859.40 | 46 | $0 (2024) |
| PFIZER INC. | $767.42 | 50 | $0 (2024) |
| Lilly USA, LLC | $636.47 | 38 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $515.39 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $390.88 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,928 | 145 | ABBVIE INC. ($597.63) |
| 2023 | $2,392 | 140 | AbbVie Inc. ($551.03) |
| 2022 | $2,436 | 148 | ABBVIE INC. ($403.40) |
| 2021 | $2,416 | 162 | AbbVie Inc. ($495.60) |
| 2020 | $1,303 | 95 | AbbVie Inc. ($246.08) |
| 2019 | $1,707 | 124 | Amgen Inc. ($295.73) |
| 2018 | $1,212 | 86 | Amgen Inc. ($197.85) |
| 2017 | $326.99 | 22 | Amgen Inc. ($74.98) |
All Payment Transactions
922 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.32 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $25.80 | General |
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/21/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Immunology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $14.24 | General |
| Category: Immunology | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/29/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 496 | 13,118 | $839,293 | $196,739 |
| 2022 | 23 | 806 | 12,362 | $789,340 | $193,477 |
| 2021 | 26 | 1,073 | 4,282 | $345,284 | $97,669 |
| 2020 | 28 | 1,224 | 4,067 | $360,062 | $94,671 |
Total Patients
3,599
Total Services
33,829
Medicare Billing
$582,556
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 12 | 9,887 | $542,401 | $103,606 | 19.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 21 | 2,040 | $77,520 | $37,750 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 345 | $102,120 | $28,439 | 27.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 24 | 112 | $39,536 | $10,543 | 26.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 16 | 88 | $17,600 | $4,128 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $15,540 | $3,907 | 25.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 151 | $9,060 | $1,604 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 25 | $5,450 | $1,565 | 28.7% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 27 | 53 | $4,428 | $1,191 | 26.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 24 | $4,080 | $920.93 | 22.6% |
| 73620 | X-ray of foot, 2 views | Office | 2023 | 24 | 47 | $3,888 | $867.15 | 22.3% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 24 | 24 | $2,760 | $657.36 | 23.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 18 | 18 | $7,200 | $638.28 | 8.9% |
| 72202 | X-ray of joint between lower spine and hip bone, 3 or more views | Office | 2023 | 16 | 16 | $1,584 | $470.56 | 29.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $365.00 | $320.87 | 87.9% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 35 | 194 | $4,850 | $98.04 | 2.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 46 | $911.00 | $32.88 | 3.6% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 11 | 8,750 | $480,025 | $97,103 | 20.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 21 | 2,100 | $79,800 | $35,901 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 378 | $111,888 | $32,945 | 29.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 18 | 69 | $24,357 | $6,904 | 28.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 24 | 124 | $24,800 | $6,287 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $10,500 | $2,772 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 23 | $5,014 | $1,487 | 29.7% |
| 73120 | X-ray of hand, 2 views | Office | 2022 | 35 | 69 | $5,740 | $1,417 | 24.7% |
About Dr. Govinda Aryal, MD
Dr. Govinda Aryal, MD is a Internal Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1083860126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Govinda Aryal, MD has received a total of $14,720 in payments from pharmaceutical and medical device companies, with $2,928 received in 2024. These payments were reported across 922 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($14,538).
As a Medicare-enrolled provider, Aryal has provided services to 3,599 Medicare beneficiaries, totaling 33,829 services with total Medicare billing of $582,556. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Greensboro, NC
- Active Since 08/08/2008
- Last Updated 02/01/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083860126
Products in Payments
- Cimzia (Drug) $1,633
- RINVOQ (Biological) $1,439
- Enbrel (Biological) $1,040
- BENLYSTA (Biological) $761.94
- XELJANZ (Drug) $686.98
- COSENTYX (Biological) $661.05
- ACTHAR (Biological) $618.22
- COSENTYX (Drug) $493.60
- EVENITY (Biological) $480.50
- TALTZ (Drug) $414.58
- SKYRIZI (Biological) $370.37
- TREMFYA (Drug) $367.57
- Rituxan (Biological) $332.31
- KRYSTEXXA (Biological) $283.41
- SAPHNELO (Biological) $280.86
- REMICADE (Biological) $255.56
- OFEV (Drug) $244.45
- Humira (Biological) $219.68
- ORENCIA (Biological) $218.81
- Kerendia (Drug) $214.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greensboro
Dr. Daniel Bensimhon, Md, MD
Internal Medicine — Payments: $2.3M
Internal Medicine $2.3M
Dr. Michael Wert, M.d, M.D
Internal Medicine — Payments: $439,242
Internal Medicine $439,242
Mark Russo, Md, MD
Internal Medicine — Payments: $318,372
Internal Medicine $318,372
Julian Hutchins, Md, MD
Internal Medicine — Payments: $222,266
Internal Medicine $222,266
Dr. James Beekman, Md, MD
Internal Medicine — Payments: $116,445
Internal Medicine $116,445
Walter Pharr, M.d, M.D
Internal Medicine — Payments: $53,823
Internal Medicine $53,823